DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Ausgabe 04 · Volume 127 · April 2019 DOI: 10.1055/s-009-42818

Article

189
Cebeci, Egemen; Cakan, Cengiz; Gursu, Meltem; Uzun, Sami; Karadag, Serhat; Koldas, Macit; Calhan, Turan; Helvaci, Serife Aysen; Ozturk, Savas: The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance
226
Karaglani, Makrina; Ragia, Georgia; Panagopoulou, Maria; Balgkouranidou, Ioanna; Nena, Evangelia; Kolios, George; Papanas, Nikolaos; Manolopoulos, Vangelis G.; Chatzaki, Ekaterini: Search for Pharmacoepigenetic Correlations in Type 2 Diabetes Under Sulfonylurea Treatment
240
Kocsis, Judit; Szekanecz, Éva; Bassam, Ali; Uhlyarik, Andrea; Pápai, Zsuzsanna; Rubovszky, Gábor; Mezősi, Emese; Rucz, Károly; Garai, Ildikó; Nagy, Endre; Uray, Iván; Horváth, Zsolt: First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis
247
Beiša, Augustas; Kvietkauskas, Mindaugas; Beiša, Virgilijus; Stoškus, Mindaugas; Ostanevičiūtė, Elvyra; Jasiūnas, Eugenijus; Griškevičius, Laimonas; Šeinin, Dmitrij; Šileikytė, Auksė; Strupas, Kęstutis: Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules

Review

203
Zemva, Johanna; Pfaff, Daniel; Groener, Jan B.; Fleming, Thomas; Herzig, Stephan; Teleman, Aurelio; Nawroth, Peter P.; Tyedmers, Jens: Effects of the Reactive Metabolite Methylglyoxal on Cellular Signalling, Insulin Action and Metabolism – What We Know in Mammals and What We Can Learn From Yeast